144 ·Filed May 20, 2026

PHVS

Pharvaris N.V.
NEUTRAL
Impact 2/10
Horizondays Processed4mo ago SEC0001950047-26-004861
Form 144 — notice of proposed sale of securities
Actionable Insight • Neutral

This is a low-concern Form 144. Director Bjork appears to be executing a cashless exercise/sale — likely to cover option exercise costs and tax obligations. No earnings catalyst or lock-up expiry coincides. The sale volume is immaterial (~0.5% of average daily volume estimate) and should not be read as a bearish signal. Monitor for Form 4 filings to confirm whether the sale actually executed.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
PHVS ▲ +15.65% at T+60d
NEUTRAL call ✓ call won +15.65% · α vs SPY +11.35% · entry $30.54 → $35.32
Entry anchored
May 20, 2026
via day open
T+1d
-2.82%
call -2.82% · α -3.26%
$29.68
settled 4mo ago
T+5d
-1.24%
call -1.24% · α -3.09%
$30.16
settled 4mo ago
T+20d
+8.07%
call +8.07% · α +7.74%
$33.01
settled 4mo ago
T+60d
+15.65%
call +15.65% · α +11.35%
$35.32
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Form 144: Director Elisabeth Bjork intends to sell 10,000 PHVS shares (~$293K) via a cashless stock option exercise. The sale is modest relative to the company's $2.0B market cap (0.015% dilution). While the insider is a director, the amount is small and routine — this is a low-significance notification of a planned sale, not a distressed liquidation.

Key Facts

  • Insider Elisabeth Bjork (Director) proposes to sell 10,000 PHVS shares
  • Estimated aggregate market value: $293,166 based on ~$29.32/share implied
  • Shares acquired via stock option exercise (cashless) on 5/20/2026
  • Sale is being conducted through Morgan Stanley Smith Barney
  • The proposed sale represents ~0.015% of the $2.0B market cap

Financial Impact

~$293K in insider selling, negligible relative to $2.0B market cap

dilution

Risk Factors

  • Form 144 is an intent notification, not a completed sale — the trade may not execute
  • Director selling at current levels may signal limited near-term upside conviction
  • Recent prior PHVS reports had negative T+5 drift, though this filing is too small to drive it

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-004861
Document: 0001950047-26-004861-index.html0001950047-26-004861
Document: 0001950047-26-004861.txt0001950047-26-004861
37 reports for PHVS
Performance horizon
90% Hit rate 9 of 10 directional calls best @ T+60▲ +21.31%Mar 20, 2026
Filters
Rows
Reports for PHVS — sortable, filterable
TypeNow
Sep 15, 2026
17d ago
Insider Cluster
BEARISH ★ 5/10
$38.06 $36.37▲ +4.44%▲ +5.26%$31.17 (+18.10%)
Sep 14, 2026
17d ago
144
NEUTRAL ★ 2/10
$38.06 $35.20▼ −7.51%▼ −9.63%$31.17 (−18.10%)
Sep 14, 2026
18d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.86 $36.02▼ −7.31%▼ −7.41%$31.17 (−19.79%)
Sep 11, 2026
21d ago
Insider Cluster
NEUTRAL ★ 3/10
$38.02 $36.37▼ −4.34%▼ −4.12%$31.17 (−18.02%)
Sep 8, 2026
24d ago
6-K
BULLISH ★ 8/10
$37.84 $38.86▲ +2.70%▲ +3.36%$31.17 (−17.63%)
Aug 12, 2026
7w ago
6-K
NEUTRAL ★ 6/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.17 (−14.51%)
Aug 12, 2026
7w ago
Press Release
BULLISH ★ 7/10
$36.46 $36.27▼ −0.52%▼ −0.08%$31.17 (−14.51%)
Aug 6, 2026
8w ago
Press Release
NEUTRAL ★ 4/10
$34.45 $34.04▼ −1.19%▼ −2.40%$31.17 (−9.52%)
Jul 6, 2026
12w ago
Press Release
BULLISH ★ 6/10
$33.22 $35.07▲ +5.57%▲ +5.08%$31.17 (−6.17%)
Jul 1, 2026
13w ago
Insider Cluster
NEUTRAL ★ 3/10
$33.86 $35.96▲ +6.20%▲ +5.27%$31.17 (−7.94%)
Showing 10 of 37

US Market Status

Market Open — Closes in 1h 35m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access